How to progress a target programme post-ELF: Publications, patents and partnering
16 April 2018
The European Lead Factory wants to see the seeded drug discovery programmes grow and have an impact on patient lives. This workshop gives insights and new ideas how to progress your drug discovery programme. Important topics include programme progress, partnering, patents and publications.
Here, you can meet the ELF scientists involved in propagating the target programmes and learn from the experts who have brought hits to the patients.
Panel discussions provide plenty of opportunity to tap into the knowledge and experience of representatives from industry, legal, investment and funding agencies. The ELF programme office will be present to answer questions on the project framework.
The workshop also provides an opportunity to meet European researchers with innovative approaches to tackle health challenges.
Chairs and panel members:
Dr Peter Roevens, Senior Director, Janssen Pharmaceutica
Prof Christopher Schofield, Programme Owner ELF & ENABLE, University of Oxford
Dr Koen Verhoef, Head of Technology Transfer Office, Netherlands Cancer Institute
Dr Daphné Derouane, Senior Patent Counsel, UCB
Prof Stan van Boekel, CSO Pivot Park Screening Centre and Professor Medicinal Chemistry, Leiden University
Representative from ELF Programme Office
What do you want to discuss? Submit your suggestion or question!
Registration and coffee
Welcome and introduction
Stefan Jaroch & Ton Rijnders
Introduction: from target to partnering
Peter Roevens (Janssen)
Planning a programme: Target lead/programme profile Panel discussion
Partnering Panel discussion
Coffee and networking
Introduction: Progressing a programme post-ELF Christopher Schofield (University of Oxford / ENABLE)